Moors & Cabot Inc. bought a new stake in shares of Tenet Healthcare Corporation (NYSE:THC – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 7,013 shares of the company’s stock, valued at approximately $1,792,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. V Square Quantitative Management LLC purchased a new stake in shares of Tenet Healthcare in the third quarter worth about $26,000. Mather Group LLC. boosted its position in shares of Tenet Healthcare by 126.9% in the third quarter. Mather Group LLC. now owns 118 shares of the company’s stock valued at $30,000 after acquiring an additional 66 shares during the period. MADDEN SECURITIES Corp purchased a new position in Tenet Healthcare during the third quarter valued at approximately $38,000. Trust Co. of Vermont purchased a new position in Tenet Healthcare during the second quarter valued at approximately $37,000. Finally, Fortitude Family Office LLC increased its holdings in Tenet Healthcare by 52.1% during the 3rd quarter. Fortitude Family Office LLC now owns 222 shares of the company’s stock worth $57,000 after acquiring an additional 76 shares during the period. 95.44% of the stock is currently owned by institutional investors.
Insider Activity
In other news, Director Richard J. Mark sold 10,000 shares of the stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the transaction, the director directly owned 25,121 shares in the company, valued at approximately $6,617,373.82. This represents a 28.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director J. Robert Kerrey sold 12,010 shares of the firm’s stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $263.72, for a total value of $3,167,277.20. Following the transaction, the director directly owned 4,794 shares in the company, valued at approximately $1,264,273.68. This represents a 71.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 99,462 shares of company stock valued at $27,081,234. 0.97% of the stock is owned by insiders.
Tenet Healthcare Stock Performance
Tenet Healthcare stock opened at $286.34 on Monday. Tenet Healthcare Corporation has a fifty-two week low of $157.58 and a fifty-two week high of $301.44. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.52 and a current ratio of 1.58. The stock has a market cap of $22.79 billion, a P/E ratio of 8.30, a price-to-earnings-growth ratio of 1.53 and a beta of 1.20. The firm’s fifty day moving average price is $267.83 and its 200-day moving average price is $224.88.
Tenet Healthcare (NYSE:THC – Get Free Report) last announced its earnings results on Thursday, October 29th. The company reported $6.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.68 by $1.96. The company had revenue of $6.28 billion during the quarter, compared to analyst estimates of $5.49 billion. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The firm’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same period in the previous year, the business earned $3.70 earnings per share. On average, equities research analysts expect that Tenet Healthcare Corporation will post 22.32 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several analysts have issued reports on THC shares. Leerink Partners increased their target price on shares of Tenet Healthcare from $309.00 to $342.00 and gave the stock an “outperform” rating in a research note on Monday, November 2nd. Stephens reissued an “overweight” rating and issued a $285.00 price target on shares of Tenet Healthcare in a report on Monday, July 27th. Weiss Ratings upgraded shares of Tenet Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a research report on Thursday, October 8th. KeyCorp upped their price target on shares of Tenet Healthcare from $270.00 to $300.00 and gave the stock an “overweight” rating in a report on Tuesday, November 3rd. Finally, Royal Bank Of Canada increased their price objective on Tenet Healthcare from $283.00 to $304.00 and gave the stock an “outperform” rating in a research report on Monday, November 2nd. Nineteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $296.65.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.
See Also
- Five stocks we like better than Tenet Healthcare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
